Funded Tech Companies

Confo Therapeutics

Confo Therapeutics is a leading healthcare services growth company, based in Ghent/Zwijnaarde. Venture capital investment was provided by Wellington Partners, Qbic Fund and BioGeneration Ventures.

Company Overview

Contact Information

Company Background Information

Overview

Confo Therapeutics' unparalleled technology stabilizes functional conformations of GPCRs (G protein-coupled receptors) to uncover a wide range of previously inaccessible GPCRs as drug targets. This technology platform combined with the pharmacologic and biologic insight it provides, allows Confo to build a multi-indication pipeline of drug candidates with the potential to transform therapeutic outcomes for patients with severe illnesses lacking disease-modifying treatments.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

7/26/2024

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Cedric Ververken

        

Chief Financial Officer

Marc Moens

        

Chief Scientific Officer

Christel Menet

        

Chief Technical Officer

Toon Laeremans

        

VP - Bus. Development

Stephen Dowd

        

VP - Bus. Development

Paolo Vicini

        

VP - General Counsel

Frank Landolt

        

Company Investors

• Wellington Partners
• Qbic Fund
• BioGeneration Ventures
• Ackermans & Van Haaren
• V-Bio Ventures
• Capricorn Healthcare
• PMV
• VIB
• Quest for Growth
• Perceptive Advisors
• University of Michigan
• Driehaus Capital Management

Browse more funded tech companies:

Conflux Technology | Conformal Medical

Share this article

About Our Venture Capital Transactions Database

This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary